Department of Psychology and Human Development, Vanderbilt University, Nashville, TN, USA.
Pediatrics. 2013 Sep;132(3):475-82. doi: 10.1542/peds.2012-2191. Epub 2013 Aug 12.
Cross-sectional studies link functional abdominal pain (FAP) to anxiety and depression in childhood, but no prospective study has evaluated psychiatric status in adulthood or its relation to pain persistence.
Pediatric patients with FAP (n = 332) and control subjects (n = 147) were tracked prospectively and evaluated for psychiatric disorders and functional gastrointestinal disorders (FGIDs) at follow-up in adolescence and young adulthood (mean age = 20.01 years). Participants were classified according to presence (FGID-POS) or absence (FGID-NEG) of FGIDs at follow-up.
Lifetime and current risk of anxiety disorders was higher in FAP than controls (lifetime: 51% vs 20%; current: 30% vs 12%). Controlling for gender and age, the odds ratio was 4.9 (confidence interval = 2.83-7.43) for lifetime anxiety disorder and 3.57 (confidence interval = 2.00-6.36) for current anxiety disorder at follow-up for FAP versus controls. Lifetime risk of depressive disorder was significantly higher in FAP versus controls (40% vs. 16%); current risk did not differ. In most cases, initial onset of anxiety disorders was before pediatric FAP evaluation; onset of depressive disorders was subsequent to FAP evaluation. Within the FAP group, risk of current anxiety disorders at follow-up was significantly higher for FGID-POS versus FGID-NEG (40% vs 24%), and both were higher than controls (12%); current depressive disorders did not differ across FGID-POS, FGID-NEG, and controls.
Patients with FAP carry long-term vulnerability to anxiety that begins in childhood and persists into late adolescence and early adulthood, even if abdominal pain resolves.
横断面研究表明,功能性腹痛(FAP)与儿童期的焦虑和抑郁有关,但尚无前瞻性研究评估成年人的精神状态及其与疼痛持续时间的关系。
前瞻性追踪患有 FAP(n=332)和对照组(n=147)的儿科患者,并在青少年和成年早期(平均年龄=20.01 岁)的随访中评估精神障碍和功能性胃肠疾病(FGIDs)。根据 FGIDs 在随访时的存在(FGID-POS)或不存在(FGID-NEG)对参与者进行分类。
与对照组相比,FAP 患者终生和当前焦虑障碍的风险更高(终生:51%比 20%;当前:30%比 12%)。在校正性别和年龄后,FAP 与对照组相比,终生焦虑障碍的优势比为 4.9(置信区间=2.83-7.43),当前焦虑障碍为 3.57(置信区间=2.00-6.36)。FAP 与对照组相比,终生抑郁障碍的风险显著更高(40%比 16%);当前风险无差异。在大多数情况下,焦虑障碍的初始发作发生在儿科 FAP 评估之前;抑郁障碍的发作发生在 FAP 评估之后。在 FAP 组中,FGID-POS 患者在随访时当前焦虑障碍的风险显著高于 FGID-NEG(40%比 24%),且均高于对照组(12%);FGID-POS、FGID-NEG 和对照组之间当前抑郁障碍无差异。
即使腹痛缓解,患有 FAP 的患者也存在长期的焦虑易感性,这种焦虑始于儿童期,并持续到青少年晚期和成年早期。